Research

rs853854 — MAPRE1 MAPRE1/EB1 Spindle Stability

An intronic PCOS susceptibility variant in MAPRE1 (chromosome 20q11.21) identified in the Day 2018 European GWAS meta-analysis; the T allele tags a haplotype associated with altered MAPRE1 expression, with mechanistic links to spindle instability and chromosome missegregation during oocyte meiosis

Moderate Risk Factor Share

Details

Gene
MAPRE1
Chromosome
20
Risk allele
T
Clinical
Risk Factor
Evidence
Moderate

Population Frequency

AA
40%
AT
47%
TT
14%

See your personal result for MAPRE1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

MAPRE1/EB1 — The Spindle Tracking Protein at the Heart of a PCOS Locus

At the growing tip of every microtubule in a dividing cell sits a small protein called EB1, encoded by MAPRE1. Its job is deceptively simple: ride the plus ends of microtubules and recruit the molecular machinery that keeps the spindle — the apparatus responsible for separating chromosomes — working properly. When EB1 fails to do this job correctly during oocyte meiosis, chromosomes can missegregate, producing aneuploid eggs that either fail to fertilize or result in miscarriage. The rs853854 variant in MAPRE1 marks a locus that a major European GWAS meta-analysis linked to polycystic ovary syndrome susceptibility, connecting a cell-biology workhorse to one of the most common causes of female reproductive difficulty.

The Mechanism

MAPRE1 encodes EB111 EB1
end-binding protein 1; a plus-end tracking (+TIP) protein that localizes to the growing tips of microtubules throughout the cell cycle. EB1 acts as a master regulator of the +TIP network, recruiting downstream effectors to microtubule ends and promoting spindle assembly
. rs853854 is an intronic variant at the MAPRE1 locus on chromosome 20q11.21 — it does not change the EB1 protein directly, but tags regulatory variation that likely influences MAPRE1 expression levels or splicing in relevant tissues.

Single-cell eQTL analysis in immune cells has identified MAPRE1 as a causal PCOS gene with regulatory effects in NK cells; the risk-associated haplotype correlates with reduced MAPRE1 expression in these cells, suggesting broader immune and ovarian effects beyond the classical androgen excess pathway.

The link to oocyte biology is direct. Zhou et al. 202122 Zhou et al. 2021
EB1 Is Essential for Spindle Formation and Chromosome Alignment During Oocyte Meiotic Maturation in Mice. Microsc Microanal 27:385–391
showed that EB1 protein localizes along the meiotic spindle, mirroring α-tubulin distribution. When EB1 was depleted using a Trim-Away approach, the consequences were severe: spindle disorganization, chromosome misalignment and missegregation, reduced conversion to mature MII oocytes, and decreased β-catenin at the cortical adherens junctional complex. The impairment of EB1 function promotes chromosomal loss — fuelling aneuploidy and potential fertilization failure.

The Evidence

Day et al. 201833 Day et al. 2018
Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet 14:e1007813
is the primary source of evidence for this variant. The study combined 10,074 PCOS cases and 103,164 controls of European ancestry in a fixed-effect inverse-variance-weighted meta-analysis, identifying 14 genome-wide significant PCOS susceptibility loci. The rs853854 locus near MAPRE1 was among three novel associations discovered, the others being near PLGRKT and ZBTB16. The authors characterized MAPRE1 as a metabolic candidate gene that interacts with LRP1 — a receptor that controls adipogenesis — and may additionally mediate ovarian angiogenesis and follicle development.

This variant has not yet been replicated at genome-wide significance in independent cohorts of comparable power, and no specific functional variant within the locus has been causally validated. The evidence level is therefore moderate: replicated within the European GWAS framework, biologically plausible via EB1's established spindle role, but lacking the cross-ethnic replication and molecular fine-mapping of more established PCOS loci like DENND1A or FSHR.

The allele frequency differs strikingly by ancestry: the T risk allele reaches 50% in Europeans but only 9% in East Asians and 16% in Africans. This suggests the variant, or a closely linked causal variant, may have experienced different selection pressures across populations.

Practical Actions

Because the MAPRE1 locus influences PCOS risk through a pathway that includes ovarian angiogenesis and potentially oocyte spindle stability, women with the T risk allele who are planning to conceive — or who are undergoing fertility treatment — have actionable considerations. Spindle stability during oocyte maturation is sensitive to oxidative stress and mitochondrial function; coenzyme Q10 supplementation has evidence for improving spindle integrity in eggs under oxidative stress. Anti-Müllerian hormone (AMH) testing combined with antral follicle count assesses the ovarian reserve and follicular health most directly affected by PCOS-related follicular arrest.

The MAPRE1 locus does not operate through the androgen excess pathway that dominates DENND1A-associated PCOS. Women carrying the rs853854 T allele alongside a normal androgen profile should not assume they are protected from PCOS-related reproductive difficulty — the MAPRE1 mechanism likely acts independently through follicular development and potential oocyte quality.

Interactions

The three novel loci identified in Day 2018 — MAPRE1, PLGRKT, and ZBTB16 — likely operate through mechanisms partly distinct from the earlier Chinese GWAS loci (DENND1A, THADA, FSHR/LHCGR). Carrying risk alleles at both MAPRE1 (rs853854) and DENND1A (rs7852296) would represent additive burden from two different PCOS pathways: spindle/follicular development (MAPRE1) and androgen excess/FSH resistance (DENND1A). No published compound effect size exists for this combination, but the biological mechanisms are sufficiently distinct that the combined phenotype may be more complex than either alone.

Genotype Interpretations

What each possible genotype means for this variant:

AA “Typical MAPRE1” Normal

Common MAPRE1 genotype — no elevated PCOS susceptibility from this locus

You carry two copies of the A allele at rs853854, the most common genotype globally (approximately 40% of people worldwide; more common in African and East Asian populations). This genotype is not associated with elevated PCOS susceptibility from the MAPRE1 locus. Overall PCOS risk depends on many additional genetic and environmental factors.

AT “One T Risk Allele” Intermediate Caution

One copy of the MAPRE1 risk allele — modestly elevated PCOS susceptibility

The Day 2018 European GWAS meta-analysis (10,074 PCOS cases, 103,164 controls) identified rs853854 near MAPRE1 as one of 14 genome-wide significant PCOS loci. MAPRE1 encodes EB1, the master microtubule plus-end tracking protein essential for spindle formation during oocyte meiosis. Mouse data (Zhou 2021) demonstrate that EB1 depletion causes spindle disorganization, chromosome missegregation, and failed oocyte maturation — directly linking reduced MAPRE1 function to aneuploidy risk. The intronic tag SNP rs853854-T marks a haplotype associated with altered MAPRE1 expression, though the causal variant has not yet been fine-mapped.

The risk allele T reaches ~50% in Europeans, making this heterozygous genotype extremely common in that population; the PCOS risk contribution per allele is modest but real, consistent with a complex-trait architecture.

TT “Two T Risk Alleles” High Risk Warning

Two copies of the MAPRE1 risk allele — elevated PCOS susceptibility and potential oocyte spindle vulnerability

The Day 2018 European GWAS meta-analysis identified the rs853854 MAPRE1 locus as one of 14 PCOS susceptibility regions. MAPRE1 encodes EB1, a microtubule plus-end tracking protein essential for meiotic spindle assembly. Mouse knockdown studies (Zhou 2021) demonstrate that EB1 loss causes spindle disorganization, chromosome misalignment, and reduced oocyte maturation — consistent with elevated aneuploidy risk. The sc-eQTL data link the PCOS risk haplotype to reduced MAPRE1 expression in NK cells, suggesting immune-ovarian axis dysregulation as a co-mechanism.

Homozygous TT carriers at this locus are exposed to the additive MAPRE1 susceptibility from both copies. MAPRE1 appears to act independently of the DENND1A androgen excess pathway; women with TT at this locus may have PCOS without classic hyperandrogenism, potentially leading to diagnostic delay. The locus interacts with LRP1-mediated adipogenesis — metabolic PCOS phenotypes (insulin resistance, dyslipidemia) should be monitored alongside reproductive parameters.

Oocyte quality is particularly vulnerable to spindle instability; even 10–25% of eggs from women in their early 30s are aneuploid under normal conditions, and this rises sharply with age. Supplements that support mitochondrial function and spindle integrity (CoQ10) have specific evidence in the context of IVF oocyte quality.